ArticleOncology letters2017

Synergistic activity of the histone deacetylase inhibitor trichostatin A and the proteasome inhibitor PS-341 against taxane-resistant ovarian cancer cell lines.

Xin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.